Telomir Pharmaceuticals, Inc. (TELO) Executive Compensation
Telomir Pharmaceuticals, Inc. (TELO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TELO
CIK: 1971532
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: FL
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Salberg & Company, P.A.
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerScott Salberg
Audit LocationBoca Raton, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-06 | 2026-10-05 | 8-K | 0001493152-26-045860 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-17 | 8-K | 0001493152-26-043053 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-11 | 8-K | 0001493152-26-042926 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001493152-26-042483 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-19 | — | DEFA14A | 0001493152-26-039116 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097283 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037854 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001493152-26-036742 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-28 | 2026-07-28 | DEF 14A | 0001493152-26-035026 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-04-16 | 4 | 0001493152-26-034813 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-04-16 | 4 | 0001493152-26-034811 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-04-16 | 4 | 0001493152-26-034812 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-15 | 8-K | 0001493152-26-028614 | View SEC Doc Filr Page |
| 3 | 2026-06-09 | 2026-06-03 | 3 | 0001493152-26-027958 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-03 | 8-K | 0001493152-26-027752 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-21 | 4 | 0001493152-26-025116 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-21 | 4 | 0001493152-26-025115 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-21 | 4 | 0001493152-26-025114 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-21 | 4 | 0001493152-26-025113 | View SEC Doc Filr Page |
| 8-K | 2026-05-20 | 2026-05-20 | 8-K | 0001493152-26-024517 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001493152-26-023010 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-24 | 8-K | 0001493152-26-019773 | View SEC Doc Filr Page |
| 4 | 2026-04-24 | 2026-04-22 | 4 | 0001493152-26-018911 | View SEC Doc Filr Page |
| 8-K | 2026-04-24 | 2026-04-22 | 8-K | 0001493152-26-018867 | View SEC Doc Filr Page |
| 8-K | 2026-03-31 | 2026-03-30 | 8-K | 0001493152-26-013872 | View SEC Doc Filr Page |